Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

America’s Overdose Epidemic In Perspective

This chart, from Statista, compares the rate of drug-induced deaths in the U.S. with other countries. . . . → Read More: America’s Overdose Epidemic In Perspective

Report: Long, Complex Effort Needed to Stem Opioid Abuse

A report released today says years of coordinated public health efforts are needed at all levels to contain and reverse the current opioid abuse epidemic. . . . → Read More: Report: Long, Complex Effort Needed to Stem Opioid Abuse

FDA Approves Sickle Cell Drug

The Food and Drug Administration today approved a new drug that reduces the tendency for blood cells in people with sickle cell disease to stick together and block blood vessels. . . . → Read More: FDA Approves Sickle Cell Drug

Device Shown to Reduce Migraine Occurrence

A clinical trial shows an electronic device worn with headphones reduces the number of days with migraines among people with a history of their occurrence. . . . → Read More: Device Shown to Reduce Migraine Occurrence

Little Health Impact Found from Engineered Mosquitoes

An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans. . . . → Read More: Little Health Impact Found from Engineered Mosquitoes

Ransomware a Small Share of Malware Threats

Infographic: This chart shows number of new malware specimens, in millions, and the share of windows-based malware, in percent. . . . → Read More: Ransomware a Small Share of Malware Threats

Nerve Stimulation Approved for Children’s Epilepsy

The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old. . . . → Read More: Nerve Stimulation Approved for Children’s Epilepsy

Second Trial Approved for Cancer Pain Drug

The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer. . . . → Read More: Second Trial Approved for Cancer Pain Drug

Long-Acting Drug Blocks Opioid Effects, Withdrawal

Findings from a clinical trial show a formulation of the drug buprenorphine given once a week blocks effects of subsequent opioid exposure and withdrawal symptoms. . . . → Read More: Long-Acting Drug Blocks Opioid Effects, Withdrawal

FDA Approves Skin Infection Drug

The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics. . . . → Read More: FDA Approves Skin Infection Drug